Kilitch Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kilitch Drugs (India) Limited has submitted a quarterly compliance certificate to BSE and NSE under SEBI Regulation 74(5). The certificate, issued by the company's Registrar and Share Transfer Agent MUFG Intime India Private Limited (formerly Link Intime), covers the quarter ended 31 March 2026. It confirms that all securities received from depository participants for dematerialization during the quarter were processed and confirmed to the depositories. The RTA also confirms that the physical security certificates were mutilated and cancelled after verification, and the depositories' names have been substituted as the registered owners within the prescribed timelines.
This is a routine regulatory compliance filing with no material impact on the company's operations, financials, or stock price. It only confirms that share dematerialization activities for the January–March 2026 quarter were carried out as required by SEBI rules.